Sumitomo Pharma America Revenue, Growth & Competitor Profile

DBA SUNOVION PHARMACEUTICALS INC.

Company Profile & Annual Report for Sumitomo Pharma America

Access the complete profile.

Sumitomo Pharma America Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	84 Waterford Dr Marlborough, MA 01752

Note: Revenues for privately held companies are statistical evaluations.


Sumitomo Pharma America's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sumitomo Pharma America's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Sumitomo Pharma America is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Sumitomo Pharma America Annual Revenue and Growth Rate

Sumitomo Pharma America	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sumitomo Pharma America's revenues are gauged from an analysis of company filings.

Sumitomo Pharma America's Income Statement (based on Industry Averages)

Sumitomo Pharma America P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Sumitomo Pharma America is developing and marketing. Sumitomo Pharma America's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
UTAARLI Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders	06/28/2023
YUZAYL Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders	06/28/2023
TAARYSMA Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders	06/28/2023

See all trademarks and details in the Full Report.

Market Share of Sumitomo Pharma America's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sumitomo Pharma America, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Sumitomo Pharma America. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SUMITOMO PHARMA AMERICA	Marlborough, MA	100
OXFORD BIOMEDICA SOLUTIONS	Bedford, MA	7
DELIX THERAPEUTICS	Concord, MA	4
SINOVENT PHARMACEUTICALS	Concord, MA	2
IMV	Sherborn, MA	2
ALLORION THERAPEUTICS	Natick, MA	2

Future Competition: Sumitomo Pharma America's Fastest Growing Competitors

These companies are in the same general field as Sumitomo Pharma America and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)